Clinical Trial Update: Study of Dust Mite Inhalation in Humans [Phase 1]

View source ↗

Summary

Phase 1 clinical trial update on inhalation of dust mite allergen in humans, evaluating safety in individuals with mild asthma or allergic conditions.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Allergic Rhinitis
• Asthma

Snippet

Sponsor: University of North Carolina, Chapel Hill | Conditions: Mild Asthma, Allergy | Phase 1 | Status: COMPLETED